Canada — Health Canada
Tracked across 49 events · 744 articles · First seen Feb 13, 2025 · Last active Aug 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Canada — Health Canada has expanded the market authorization of Bayer's elinzanetant (brand name Lynkuet) to treat moderate to severe hot flashes and night sweats in breast cancer patients. The drug was first approved in…
Impact: Regulatory authority that granted the expanded authorization, enabling the drug's use in breast cancer patients.
Aug 17, 2026 · 6 articles
Regulatory
Grifols, a Spain-based for-profit plasma donation company, announced on August 13, 2026, that it would temporarily pause plasma collection at all its Canadian clinics. The decision came amid public scrutiny and regulatory pressure following the…
Impact: Canada — Health Canada is the regulator that issued non-compliance ratings and imposed conditions on Grifols, leading to the pause. It is working to ensure compliance before allowing reopening.
Aug 13, 2026 · 6 articles
Business
Impact: Canada — Health Canada granted the Medical Device License to ClearPoint Neuro for its Neuro Navigation System, facilitating its use in Canadian neurosurgery centers.
Apr 20, 2026 · 6 articles
Regulatory
Impact: Canada — Health Canada is the regulatory body reviewing Diagnosis's CARA System application. Its guidance and approval are crucial for the system's market entry in Canada.
Jun 16, 2026 · 9 articles
Regulatory
Impact: Canada — Health Canada granted a Class II medical device licence to Diagnosis for the CARA System, marking a regulatory approval.
Jul 27, 2026 · 6 articles
Regulatory
Impact: Canada — Health Canada granted Notice of Compliance for Biocon's Yesintek autoinjector, following earlier approvals for other formulations. The regulator's decision enables a new treatment option for Canadian patients.
Jul 29, 2026 · 6 articles
Regulatory
Bracco S.p.A. — Bracco Imaging announced on August 11, 2026, that its VueJect ultrasound contrast delivery system received 510(k) clearance from the U.S. United States — Food and Drug Administration and authorization from Canada —…
Impact: Canada — Health Canada authorized VueJect under Medical Device License No. 115637, permitting its sale in Canada.
Aug 11, 2026 · 7 articles
Domestic
Impact: Canada — Health Canada is the government agency responsible for drug approval processes in Canada. Bill C-286 seeks to streamline its Special Access Program for psilocybin and psilocin, which has been criticized for slow and unpredictable approvals.
Jun 16, 2026 · 6 articles
Business
Impact: Canada — Health Canada published notices regarding the Peloton Interactive recall, affecting units sold in Canada and advising owners to seek a free seat post replacement.
Nov 06, 2025 · 14 articles
Business
Impact: Canada — Health Canada is the regulatory body providing initial feedback to MedMira regarding the approval process for its Multiplo Complete Syphilis Antibody Test.
Jun 30, 2026 · 6 articles
Business
Impact: Canada — Health Canada's regulation of ibogaine under the Food and Drugs Act and its listing on the Prescription Drug List provides a favorable regulatory environment for Optimi Health's operations.
Jun 08, 2026 · 14 articles
Business
Impact: Canada — Health Canada is the regulatory body whose approval is required for Medexus Pharmaceuticals to begin commercializing Allogeneic umbilical cord-derived CD34- cells, non-expanded/dorocubicel in Canada.
Jun 10, 2026 · 6 articles
Tech
Impact: Canada — Health Canada>>> has not yet received an application to license daraxonrasib in Canada>>>. Its role is to regulate and approve new drugs for use in the country, impacting the timeline for Canadian patient access.
May 29, 2026 · 74 articles
Business
Impact: Diagnosis is pursuing regulatory clearance with Canada — Health Canada>>> for its CARA platform, a key milestone for market expansion in Canada.
Jun 05, 2026 · 11 articles
Domestic
As of August 1, 2026, the province of Canada — Saskatchewan began publicly covering Alyftrek, a cystic fibrosis (CF) medication developed by Vertex Pharmaceuticals, for eligible patients aged six and older who meet specific medical…
Impact: Canada — Health Canada's recommendation in July 2025 facilitated provincial coverage decisions, playing a regulatory role in the drug's availability.
Aug 04, 2026 · 6 articles
Regulatory
Impact: Canada — Health Canada provided scientific advice on the trial design, consistent with its regulatory role; no direct impact on the agency.
Jul 06, 2026 · 6 articles
Accidents
The Democratic Republic of the Congo is experiencing its deadliest Ebola outbreak on record, caused by the rare Bundibugyo ebolavirus. As of August 19, 2026, the outbreak has surpassed 5,000 confirmed cases and over 2,300…
Impact: Authorized Moderna's clinical trial, playing a regulatory role in vaccine development.
Aug 01, 2026 · 295 articles
Business
Knight Therapeutics Inc. announced the launch of WYNZORA, a topical cream for psoriasis vulgaris, in Canada. WYNZORA is a fixed-dose combination of calcipotriol and betamethasone dipropionate, developed by MC2 Therapeutics using its PAD Technology platform.…
Impact: Canada — Health Canada approved WYNZORA in December 2025, a regulatory prerequisite for the launch.
Aug 20, 2026 · 6 articles
Regulatory
Impact: Canada — Health Canada issued a corresponding notice for the recall of Ryobi pressure washers in Canada, ensuring consumer safety in the region.
Aug 28, 2025 · 7 articles
Regulatory
Impact: Canada — Health Canada is the regulatory body in Canada to which Diagnosis plans to submit CARA for approval, impacting its commercialization in Canada.
Apr 08, 2026 · 6 articles
Tech
Impact: Canada — Health Canada approved the urgent application for exosome therapy on compassionate grounds, allowing the world-first treatment to proceed.
Jun 15, 2026 · 6 articles
Business
Impact: Canada — Health Canada issued the Drug Establishment Licence (DEL) to Optimi Health, authorizing the company's manufacturing, packaging, labeling, testing, storage, and distribution of controlled drug products.
Jun 02, 2026 · 25 articles
Business
Impact: Canada — Health Canada is the issuer of the Controlled Substances Dealer's Licence that Lophos Pharmaceuticals Corporation previously held, impacting the company's ability to conduct controlled substance activities.
Jun 12, 2026 · 6 articles
Accidents
Impact: Canada — Health Canada advises on safety guidelines for inflatable structures, and its recommendations are highlighted in the context of this accident.
Jun 02, 2026 · 6 articles
Regulatory
On August 13, 2026, Diagnosis Inc., a Canadian company specializing in AI-based early detection of eye diseases, announced that it received Medical Device Marketing Authorization for its CARA System from the Saudi Arabia — Saudi…
Impact: Canada — Health Canada's prior approval in July 2026 is referenced as a recent milestone, but it is not directly part of this event.
Aug 13, 2026 · 6 articles
Regulatory
Impact: Approved lecanemab in October 2025; not directly involved in funding decision.
Jul 16, 2026 · 7 articles
Business
Impact: Canada — Health Canada provides supportive regulatory frameworks that facilitate product approvals and market growth in Canada.
Jul 28, 2026 · 6 articles
Business
Impact: Canada — Health Canada approval for Kane's products enables commercial sales in Canada, contributing to the company's market presence.
Aug 05, 2026 · 7 articles
Tech
Impact: Canada — Health Canada has issued a Drug Establishment License (DEL) to Optimi Health Corp., allowing it to produce and distribute regulated psychedelic drug products.
Jun 16, 2026 · 11 articles
Business
Impact: Canada — Health Canada regulations are a key area of Dell Technologies's expertise, which Registrar Corp will now offer to its clients.
Apr 16, 2026 · 6 articles
+ 19 more events
View on Dashboard
100
Canada — Health Canada authorized BayerHealth Canada approves...
90
Canada — Health Canada authorized clinical trial ModernaDR Congo Ebola outbreak...
90
Canada — Health Canada granted authorization Bracco S.p.A. — Bracco ImagingBracco VueJect FDA and...
80
Canada — Health Canada issued non-compliance rating GrifolsGrifols pauses Canadian...
75
Moderna started Phase 1 trial Canada — Health CanadaDR Congo Ebola outbreak...
70
Canada — Health Canada imposed licence conditions GrifolsGrifols pauses Canadian...
60
Canada — Health Canada recommended coverageSaskatchewan expands...
40
Katherine Lanteigne urged licence suspension Canada — Health CanadaGrifols pauses Canadian...
ERGEN INTELLIGENCE
Track Canada — Health Canada live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard